在COPD中,HIF1-A表达和气道重塑之间的相关性
Lingfang Tan1, Xuefeng Yang2, Jianxin Zhang3
1The Nanhua Affiliated Hospital, Department of Respiratory Physicians, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, People's Republic of China.
概括
低氧诱导因子1-α (HIF-1α) 在慢性阻塞性肺病 (COPD) 患者中升高,与呼吸道重塑相关. 这表明HIF-1α可能作为COPD呼吸道变化的生物标志物.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 呼吸道改造是慢性阻塞性肺病 (COPD) 的一个关键特征.
- 低氧诱导因子1-α (HIF-1α) 在COPD呼吸道改造中的作用尚不清楚.
- 研究HIF-1α可能会揭示COPD的新治疗点.
研究的目的:
- 为了检查COPD患者的HIF-1α表达.
- 为了确定HIF-1α和COPD中呼吸道重塑之间的关联.
- 探索HIF-1α作为COPD气道改造的潜在生物标志物.
主要方法:
- 包括60名COPD患者和28名对照.
- 使用免疫组织化学来评估HIF-1α和MMP9在气道组织中的表达.
- 通过ELISA测量血清HIF-1α和MMP9.
- 分析了用于气道改造的CT扫描参数.
主要成果:
- 慢性肺炎患者的呼吸道重塑显著,包括纤维化.
- 在COPD呼吸道组织和血清中观察到高的HIF-1α和MMP9水平.
- CT扫描证实了COPD患者的气道改造和增加的气道参数.
结论:
- 增加HIF-1α表达与COPD的呼吸道重塑有关.
- HIF-1α显示出作为COPD气道改造生物标志物的潜力.
- 这些发现可能会指导未来的COPD治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Pathogenesis and Clinical Features
267
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
267


